Rosemary Perez
Physician Assistant · Elmhurst, NYNPI 1477901361
Payments from drug & device makers
Across 274 payments — averaging $23.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$895
- Amneal Pharmaceuticals LLC$625
- Amgen$547
- AbbVie$521
- Cequr Corporation$508
- Lilly USA, LLC$486
- plus $3K from 27 others
What the payments were for
- Food & beverage$6,517100%
- Education$280%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 43 | $895 |
| Amneal Pharmaceuticals LLC | 42 | $625 |
| Amgen(2 entities) | 29 | $547 |
| AbbVie | 18 | $521 |
| Cequr Corporation | 3 | $508 |
| Lilly USA, LLC | 20 | $486 |
| Corcept Therapeutics | 15 | $386 |
| Boehringer Ingelheim | 16 | $358 |
| Bayer | 11 | $231 |
| Xeris Pharmaceuticals, Inc. | 8 | $226 |
| Insulet Corporation | 9 | $199 |
| Medtronic | 5 | $191 |
| Ascendis Pharma Endocrinology Inc | 3 | $177 |
| Dexcom, Inc. | 6 | $141 |
| Abbott | 5 | $127 |
| Amryt Pharma Holdings Ltd | 5 | $124 |
| Chiesi USA, Inc. | 4 | $105 |
| Vanda Pharmaceuticals Inc. | 4 | $99 |
| Tandem Diabetes Care, Inc. | 4 | $87 |
| Eisai Inc. | 3 | $72 |
| Pfizer | 3 | $56 |
| Radius Health, Inc. | 3 | $55 |
| Averitas Pharma Inc. | 2 | $48 |
| Mannkind Corporation | 2 | $43 |
| Amarin Pharma, Inc. | 2 | $36 |
| Vistapharm, Inc. | 2 | $36 |
| Neurocrine Biosciences, Inc. | 1 | $31 |
| Intra-sana Laboratories | 1 | $29 |
| Madrigal Pharmaceuticals | 1 | $28 |
| Zealand Pharma US, Inc. | 1 | $24 |
| IBSA Pharma Inc. | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Merck | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CeQur Simplicity$447
- Yorvipath$125
- LINZESS$125
How this compares
$6,545 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 270 | $263,865 |
| JardianceEmpagliflozin | 142 | $115,327 |
| MounjaroTirzepatide | 63 | $66,030 |
| JanuviaSitagliptin Phosphate | 84 | $63,748 |
| JanumetSitagliptin Phos/Metformin Hcl | 53 | $47,005 |
| FarxigaDapagliflozin Propanediol | 53 | $42,525 |
| TrulicityDulaglutide | 37 | $40,392 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 57 | $37,920 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 112 | $36,343 |
| ProliaDenosumab | 20 | $33,544 |
| Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp | 97 | $25,936 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 32 | $22,705 |
| Novolog FlexpenInsulin Aspart | 121 | $21,283 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 12 | $17,576 |
| TradjentaLinagliptin | 28 | $15,227 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Novolog | $895 | $266,675282 claims |
| MerckJanuvia, Janumet, Janumet Xr, Steglatro | $15 | $138,823185 claims |
| Boehringer IngelheimJardiance, Tradjenta | $358 | $130,554170 claims |
| Lilly USA, LLCMounjaro, Trulicity | $486 | $106,422100 claims |
| AmgenProlia | $547 | $33,54420 claims |
| AbbVieSynthroid | $521 | $11,839169 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $625 | $2,612313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 11,358 physician assistant providers in New York.
Other physician assistant in Elmhurst
- Emmanuel AgnantElmhurst$66K
- Henry YuBronx$1M
- Michael AsbachAmherst$962K
- Janelle BunceJamestown$565K
- Kristyl Cuenca-SiskoNew York$478K
- Melissa WhiteGarden City$320K
- Lawrence HermanHolbrook$315K
- Kaitlyn NelsonBrooklyn$289K
- Sari KatzGarden City$271K
- Julius NwosuBronx$256K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.